Hyderabad (Telangana) [India], March 20 (ANI): Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of ...

COVID-19 vaccines in India: Bharat Biotech's Covaxin phase-3 trial crosses half-way mark Hyderabad-based Bharat Biotech began phase-3 human clinical trials of its COVID-19 vaccine, called Covaxin ...

Hyderabad, Jun 3 () The Coalition for Epidemic Preparedness Innovations (CEPI) will provide a fund of USD 14.1 million to a consortium, comprising Bharat Biotech and International Vaccine ...

India's laboratory Bharat Biotech is still waiting for clearance on the part of the Asian country's Government for the shipment of the 2 million doses of anticoronavirus vaccines purchased by ...

Bharat Biotech has emphasised the need for more comprehensive data to ensure unbiased and informative safety evaluations. Several studies have reported rare side effects from AstraZeneca's vaccine ...